# data[].attributes.body
Information about the ivWatch was gathered from Medgadget.com and a current ongoing study from Queensland Children's Hospital in Brisbane Australia. The current study being conducted at Queensland Children's Hospital is utilizing the ivWatch within a 36 bed PICU with patient population of neonates to 17 year old pediatric patients (McBride et al., 2022).

As a NICU RN it is critical task to complete a minimal  hourly  check on PIV's within the NICU population. Fluids that contain TPN and/or lipids are very caustic to veins and if infiltration occurs it can cause severe burns, pain, and tissue damage to the neonatal skin.

# data[].attributes.body
ivWatch:

A SmartTouch sensor that detects extravasation and IV infiltration in patients with peripheral intravenous catheters. The device can provide audio and visual warnings to clinicians that a problem has been detected (Megadget 2020).

# data[].attributes.headline
SOURCE DETAILS AND DATE PUBLISHED: ivWatch - Medgaget-2020

# data[].attributes.subject
SOURCE DETAILS AND DATE PUBLISHED: ivWatch - Medgaget-2020

# data[].attributes.body
Overview of the product and its functionality within NICU/PICU/ Pediatric settings.

# data[].attributes.attachment_link.readable_text
ivWatch, a company based in Newport News, Virginia, won FDA clearance for its SmartTouch sensor that detects peripheral IV infiltration and extravasation events. Though somewhat rare, these can be difficult to notice and a late response can lead to grave consequences. The SmartTouch sensor can warn physicians that something is wrong, sometimes hours before a clinician would notice any visual or tactile changes on the patient's body.

The sensor, which is already cleared in Europe, is a single-use disposable device that can be used on patients of any age, including those in the neonatal intensive care unit. Thanks to the SmartTouch, clinicians can take advantage of additional options in terms of where to place the IV, which is especially important for neonates, to choose longer dwell times, and to keep an eye on active patients that may be ambulatory at times.

The device, which uses visible and near-infrared light to penetrate the skin, can be used alongside the ivWatch Patient Monitor that algorithmically analyzes the optical signatures of tissue around the IV site while compensating for patient movements. The system can detect changes as small as .2 mL of IV fluid, with an average detection volume of 2.02 mL, according to ivWatch. Any adverse events are immediately relayed to the clinical team for a quick response.

The adhesive on the back side of the sensor is breathable, leading to minimal irritation and compatibility with existing IV dressings.

More from ivWatch regarding the tested efficacy of the SmartTouch:

A series of seven IRB-approved studies were conducted to test the efficacy and safety of the SmartTouch Sensor. Five verification studies were conducted to understand the performance and optimize ivWatch's proprietary algorithm to maximize sensitivity to infiltrated tissues, while limiting the number of false notifications issued. Two validation studies were conducted to investigate device sensitivity and false notification rates.

Clinical data shows that the SmartTouch Sensor issued notifications for 99.0%* of early stage infiltrations in less than 10 mL of infused IV fluid. Results also showed less than one false notification was issued every six days, therefore having minimal contribution to clinician alarm fatigue.[3],[4],[5] The majority of the non-infiltration notifications were attributed to a force applied to the IV site, which may beneficially notify clinicians of conditions that could place the peripheral IV site at a greater risk for complications. ivWatch also has a proven record of detecting IV infiltrations an average of 15 hours before the clinician.[2]

Flashbacks: ivWatch Detects IV Infiltrations and Extravasations: Interview with Gary Warren, President and CEO; ivWatch Monitors IV Placement Sites for Leakage Outside Veins; ivWatch IV Infiltration Detection Device Cleared in Europe; ivWatch Detects Leaks Near IV Placement Sites;

Product page: SmartTouch Sensor

Via: ivWatch

# data[].attributes.attachment_link.title
ivWatch Monitors IV Placement Sites for Leakage, Now Cleared by FDA |

# data[].attributes.attachment_link.description
ivWatch, a company based in Newport News, Virginia, won FDA clearance for its SmartTouch sensor that detects peripheral IV infiltration and extravasation events. Though somewhat rare, these can be difficult to notice and a late response can lead to grave consequences.

# data[].attributes.body
Early Detection

Device can detect as small as 0.2 mL of fluid infiltration

Improved patient safety

Audio and Visual notification system

Individual disposable sensor

Nurse satisfaction

Possible reduction of central line placement due to more PIV insertions for caustic infusions that now can be monitored closer for infiltration (which in return would reduce CLABSI infection risk)

# data[].attributes.body
- False Notifications
- User Error
- Cost of equipment, maintenance, and upkeep of equipment
- Additional sensor to be placed on skin that, in Neonates, is fragile and prone for skin breakdown
- May not be appropriate for micro-preemie due to immaturity of skin
- how often will the device need to be rotated in order to prevent skin breakdown, could cause disruption in sleep patterns of neonates.

# data[].attributes.body
My top 5 Clifton Strenths:
1. Achiever
2. Competition
3. Woo
4. Activator
5. Significance

I. Achiever:

Achiever being my top strength is helpful because of my  hard work ethic and dedication to being productive. every day . It is the achiever strength that I possess that completion of the project is always on my mind and I won't shy away from launching this new project/product within my unit.

2. Competition:

This person brings with them the ability to be the best; and this is what the competition brings out in me and transferring this onto my team. Individuals with this asset will prove to be useful in finding the best possible outcome and making it a priority for the product to succeed.

3. Woo:

This person is all about winning the approval and others. I will strive to make connections with others and my openness can draw others into conversation. This is a great quality when trying to convince others to use and understand new products.

4. Activator:

Activators are the people who make things happen.
The activator strength in me will use my enthusiasm and optimism to challenge others to see things in another light. I have no problem being outspoken about this product and I plan to be clever in my abilities to energize others.

5. Significance:

With this strength my independence to lead and desire to surround myself with likeminded team members will be essential in making this project successful. This strength will allow me to take charge of the project and encourage others to excel.

# data[].attributes.body
TEAM MEMBERS:

1 - Alice - Achiever (Executing):
Achiever as the top strength will assure that things get done. She has the drive that is needed for implementation of new products and assimilating them into a culture that is driven by Type A personalities.

2 - Carter - Communication (Influencing):

Carter's ability to communicate with others and focus on each team member individually will prove useful when educating about the product. When implementation or troubleshooting issues arise it will take Carter's communication abilities to focus team members and get them to buy into change

3 - Faith - Futuristic (Strategic Thinking)

Products that are new, innovative, and no longer "that is how it is always done" require a futuristic thinker to promote advancement and change. Faith will be able to help team members see the relevance of the product and the implications the product will have on our patient population.

4 - David - Deliberative (Executing)

New products come with road obstacles  and troubleshooting, David is the team member who can best assist Faith in trying to navigate both. David will be the go to person for finding solutions.

5 - Emily - Empathy (Relationship building)

This is the person that is essential for my specific team. I have no strengths within the category of relationship building. Due to this , I need someone like Emily who is strong in Empathy and will be able to maintain primary focus on the babies and their families. Emily is needed to remember the person first and foremost; not just a "product" focus.

# data[].attributes.body
The ivWatch has potential to have a great future in NICU's across the county. The fact that it can detect 0.2 mL of extracellular fluid under the skin is remarkable. Studies in the United States are needed before the product can be mainstreamed into NICU's. The current study being conducted in Queensland Children's Hospital will provide essential data to support the safe use of the product (Craig et al., 2022).
One concern for the use of the ivWatch in the neonatal population is Medgaget reported an average detection volume of 2.02 mL (Medgaget 2020). In addition, this product might not be appropriate for micro preemies or infant's under 2 kg; continued research and parameters are needed.